Investing in tomorrow's healthcare

About Angels in MedCity

Investing in tomorrow's healthcare

With a particular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector.

The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.

The Angels in MedCity initiative is delivered by Newable and MedCity with further expertise from Angels4LifeSciences. Our initiative provides practical support to investors and small businesses that supports investment funding and thereby helps to create jobs in London.

Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

We hold regular entrepreneur pitching events, which give pre-vetted and investment ready early-stage life sciences companies an opportunity to pitch to the Angels in MedCity investor community.

Since the programme launch in October 2014, we have held seven pitching events, helping 43 healthcare/life sciences companies to raise equity funding from our community of business angels, with £14m being invested so far. See a full list of companies with succesful investments here:

For further details on how to get involved in the programme please contact:




Become an Angels in MedCity investor

Become an investor >


Become an Angels in MedCity entrepreneur

Entrepreneurs >


On Twitter

RT @joreis13: Thank you to all the investors that attended @AngelsInMedCity pitching event last night @TheCrick! Stay tuned for our next ev…
7 hours 55 min ago
RT @Neelam_P1: Last panel chaired by Sarah Haywood @MedCityHQ discussing the difficult topic of pricing a digital therapeutic. @DHealthLDN
11 hours 51 min ago